DDIS-21. IN VITRO MICRODIALYSIS RECOVERY OF TRAMETINIB

BACKGROUND: Dysregulation of the mitogen-activated protein kinase and phosphoinositide 3-kinase (PI3K) pathways is common in several primary brain tumors and metastatic cancers affecting the central nervous system. Trametinib, and oral MEK1/2 inhibitor, has been effective in preclinical studies agai...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Romo, Carlos, Anders, Nicole, Scardina, Morgan, Mukherjee, Debraj, Grossman, Stuart, O Blakeley, Jaishri, Rudek-Renaut, Michelle
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Drug Discovery
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847899/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.272
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky